Last 12 months
Inside the activity.
8 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 7 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2025 Filed Jun 6, 2025 00:05 UTC |
Desai Antal RohitDirector
|
SaleCommon Stock | 8,600 | $61.40 | $528,052.04 |
DisclosureSEC source: 0001628280-25-029800 · wk-form4_1749168189.xml · nonDerivative · entry 7 Desai Antal Rohit · CIK 0001881616 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By The 2:22 DNA Trust Disclosed balance after: 114,363 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.13 to $61.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 00:05 UTC |
Desai Antal RohitDirector
|
SaleCommon Stock | 16,400 | $60.82 | $997,503.76 |
DisclosureSEC source: 0001628280-25-029800 · wk-form4_1749168189.xml · nonDerivative · entry 6 Desai Antal Rohit · CIK 0001881616 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By The 2:22 DNA Trust Disclosed balance after: 122,963 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.13 to $61.125, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 03, 2025 Filed Jun 6, 2025 00:05 UTC |
Desai Antal RohitDirector
|
SaleCommon Stock | 1,518 | $61.83 | $93,855.97 |
DisclosureSEC source: 0001628280-25-029800 · wk-form4_1749168189.xml · nonDerivative · entry 5 Desai Antal Rohit · CIK 0001881616 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By The 2:22 DNA Trust Disclosed balance after: 139,363 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.74 to $61.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 03, 2025 Filed Jun 6, 2025 00:05 UTC |
Desai Antal RohitDirector
|
SaleCommon Stock | 11,602 | $61.22 | $710,228.03 |
DisclosureSEC source: 0001628280-25-029800 · wk-form4_1749168189.xml · nonDerivative · entry 4 Desai Antal Rohit · CIK 0001881616 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By The 2:22 DNA Trust Disclosed balance after: 140,881 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.74 to $61.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 03, 2025 Filed Jun 6, 2025 00:05 UTC |
Desai Antal RohitDirector
|
SaleCommon Stock | 9,880 | $60.23 | $595,094.14 |
DisclosureSEC source: 0001628280-25-029800 · wk-form4_1749168189.xml · nonDerivative · entry 3 Desai Antal Rohit · CIK 0001881616 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By The 2:22 DNA Trust Disclosed balance after: 152,483 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.74 to $60.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 03, 2025 Filed Jun 6, 2025 00:05 UTC |
Desai Antal RohitDirector
|
SaleCommon Stock | 1,100 | $59.14 | $65,058.95 |
DisclosureSEC source: 0001628280-25-029800 · wk-form4_1749168189.xml · nonDerivative · entry 2 Desai Antal Rohit · CIK 0001881616 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By The 2:22 DNA Trust Disclosed balance after: 162,363 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.73 to $59.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 03, 2025 Filed Jun 6, 2025 00:05 UTC |
Desai Antal RohitDirector
|
SaleCommon Stock | 900 | $58.04 | $52,237.89 |
DisclosureSEC source: 0001628280-25-029800 · wk-form4_1749168189.xml · nonDerivative · entry 1 Desai Antal Rohit · CIK 0001881616 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By The 2:22 DNA Trust Disclosed balance after: 163,463 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.65 to $58.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 09, 2025 Filed May 13, 2025 20:59 UTC |
Zadno RezaDirector · President, CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 13,759 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001628280-25-025179 · wk-form4_1747169964.xml · derivative · entry 2 Zadno Reza · CIK 0001632326 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,871 Underlying: Common Stock · 13,759 shares Expires 2031-06-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Stock option was granted on June 22, 2021 and vests 25% on the six month anniversary of the grant date and the remainder vests on each monthly anniversary over a four year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date. Read SEC document |
| May 09, 2025 Filed May 13, 2025 20:59 UTC |
Zadno RezaDirector · President, CEO
|
Exercise / conversionCommon Stock | 13,759 | $7.27 | $100,027.93 |
DisclosureSEC source: 0001628280-25-025179 · wk-form4_1747169964.xml · nonDerivative · entry 1 Zadno Reza · CIK 0001632326 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2025 Filed Mar 19, 2025 20:16 UTC |
Zadno RezaDirector · President, CEO
|
SaleCommon Stock | 5,475 | $57.06 | $312,403.50 |
DisclosureSEC source: 0001628280-25-013832 · wk-form4_1742415395.xml · nonDerivative · entry 1 Zadno Reza · CIK 0001632326 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,070 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. F2 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| March 18, 2025 Filed Mar 19, 2025 20:04 UTC |
Nouri AlalehEVP, CLO, CORP. SEC.
|
SaleCommon Stock | 316 | $57.06 | $18,030.96 |
DisclosureSEC source: 0001628280-25-013813 · wk-form4_1742414660.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,473 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. F2 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| March 18, 2025 Filed Mar 19, 2025 20:15 UTC |
Waters KevinEVP, CFO
|
SaleCommon Stock | 733 | $57.06 | $41,824.98 |
DisclosureSEC source: 0001628280-25-013830 · wk-form4_1742415331.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,991 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. F2 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| March 18, 2025 Filed Mar 19, 2025 20:08 UTC |
Shiblaq HishamEVP, Chief Comm. Officer
|
SaleCommon Stock | 247 | $57.06 | $14,093.82 |
DisclosureSEC source: 0001628280-25-013817 · wk-form4_1742414903.xml · nonDerivative · entry 1 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,133 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. F2 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 20:26 UTC |
Zadno RezaDirector · President, CEO
|
SaleCommon Stock | 15,916 | $61.31 | $975,809.96 |
DisclosureSEC source: 0001628280-25-011700 · wk-form4_1741638404.xml · nonDerivative · entry 1 Zadno Reza · CIK 0001632326 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,545 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. F2 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 20:31 UTC |
Nouri AlalehEVP, CLO, CORP. SEC.
|
SaleCommon Stock | 3,641 | $61.31 | $223,229.71 |
DisclosureSEC source: 0001628280-25-011710 · wk-form4_1741638660.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,789 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. F2 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 20:29 UTC |
Shiblaq HishamEVP, Chief Comm. Officer
|
SaleCommon Stock | 3,588 | $61.31 | $219,980.28 |
DisclosureSEC source: 0001628280-25-011707 · wk-form4_1741638582.xml · nonDerivative · entry 1 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,380 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. F2 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 20:28 UTC |
Waters KevinEVP, CFO
|
SaleCommon Stock | 3,662 | $61.31 | $224,517.22 |
DisclosureSEC source: 0001628280-25-011703 · wk-form4_1741638492.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,724 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. F2 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:30 UTC |
Zadno RezaDirector · President, CEO
|
GrantStock Option (Right to Buy) · Derivative | 36,831 | $0.00 Strike: $60.60 | $0.00 |
DisclosureSEC source: 0001628280-25-010596 · wk-form4_1741213805.xml · derivative · entry 2 Zadno Reza · CIK 0001632326 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,831 Underlying: Common Stock · 36,831 shares Expires 2035-03-02 F2 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2025 over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:30 UTC |
Zadno RezaDirector · President, CEO
|
GrantCommon Stock | 41,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-010596 · wk-form4_1741213805.xml · nonDerivative · entry 1 Zadno Reza · CIK 0001632326 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,461 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2026, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:36 UTC |
Nouri AlalehEVP, CLO, CORP. SEC.
|
GrantStock Option (Right to Buy) · Derivative | 11,445 | $0.00 Strike: $60.60 | $0.00 |
DisclosureSEC source: 0001628280-25-010628 · wk-form4_1741214157.xml · derivative · entry 2 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,445 Underlying: Common Stock · 11,445 shares Expires 2035-03-02 F2 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2025, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:36 UTC |
Nouri AlalehEVP, CLO, CORP. SEC.
|
GrantCommon Stock | 12,958 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-010628 · wk-form4_1741214157.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,430 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2026, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:34 UTC |
Shiblaq HishamEVP, Chief Comm. Officer
|
GrantStock Option (Right to Buy) · Derivative | 9,810 | $0.00 Strike: $60.60 | $0.00 |
DisclosureSEC source: 0001628280-25-010616 · wk-form4_1741214062.xml · derivative · entry 2 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,810 Underlying: Common Stock · 9,810 shares Expires 2035-03-02 F2 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2025, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:34 UTC |
Shiblaq HishamEVP, Chief Comm. Officer
|
GrantCommon Stock | 11,107 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-010616 · wk-form4_1741214062.xml · nonDerivative · entry 1 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,968 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2026, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:32 UTC |
Waters KevinEVP, CFO
|
GrantStock Option (Right to Buy) · Derivative | 14,388 | $0.00 Strike: $60.60 | $0.00 |
DisclosureSEC source: 0001628280-25-010602 · wk-form4_1741213906.xml · derivative · entry 2 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,388 Underlying: Common Stock · 14,388 shares Expires 2035-03-02 F2 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2025, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:32 UTC |
Waters KevinEVP, CFO
|
GrantCommon Stock | 16,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-010602 · wk-form4_1741213906.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,386 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2026, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 22:39 UTC |
MOLL FREDERIC HDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,263 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001628280-25-005209 · wk-form4_1739399980.xml · derivative · entry 4 MOLL FREDERIC H · CIK 0001260157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,263 shares Expires 2025-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock option is fully vested and exercisable. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 22:39 UTC |
MOLL FREDERIC HDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 26,749 | $0.00 Strike: $1.33 | $0.00 |
DisclosureSEC source: 0001628280-25-005209 · wk-form4_1739399980.xml · derivative · entry 3 MOLL FREDERIC H · CIK 0001260157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,749 shares Expires 2025-09-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock option is fully vested and exercisable. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 22:39 UTC |
MOLL FREDERIC HDirector
|
Exercise / conversionCommon Stock | 5,263 | $0.86 | $4,526.18 |
DisclosureSEC source: 0001628280-25-005209 · wk-form4_1739399980.xml · nonDerivative · entry 2 MOLL FREDERIC H · CIK 0001260157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 841,621 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 22:39 UTC |
MOLL FREDERIC HDirector
|
Exercise / conversionCommon Stock | 26,749 | $1.33 | $35,576.17 |
DisclosureSEC source: 0001628280-25-005209 · wk-form4_1739399980.xml · nonDerivative · entry 1 MOLL FREDERIC H · CIK 0001260157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 836,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:20 UTC |
Zadno RezaDirector · President, CEO
|
SaleCommon Stock | 2,235 | $99.04 | $221,359.32 |
DisclosureSEC source: 0001628280-24-050224 · wk-form4_1733520032.xml · nonDerivative · entry 4 Zadno Reza · CIK 0001632326 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 152,762 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.97 to $99.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:20 UTC |
Zadno RezaDirector · President, CEO
|
SaleCommon Stock | 5,126 | $98.09 | $502,807.80 |
DisclosureSEC source: 0001628280-24-050224 · wk-form4_1733520032.xml · nonDerivative · entry 3 Zadno Reza · CIK 0001632326 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 154,997 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.66 to $98.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:20 UTC |
Zadno RezaDirector · President, CEO
|
SaleCommon Stock | 13,762 | $97.01 | $1,335,065.38 |
DisclosureSEC source: 0001628280-24-050224 · wk-form4_1733520032.xml · nonDerivative · entry 2 Zadno Reza · CIK 0001632326 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 160,123 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.65 to $97.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:20 UTC |
Zadno RezaDirector · President, CEO
|
SaleCommon Stock | 5,300 | $96.15 | $509,611.96 |
DisclosureSEC source: 0001628280-24-050224 · wk-form4_1733520032.xml · nonDerivative · entry 1 Zadno Reza · CIK 0001632326 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 173,885 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.65 to $96.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:17 UTC |
Nouri AlalehEVP, CLO, CORP. SEC.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,092 | $0.00 Strike: $37.02 | $0.00 |
DisclosureSEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · derivative · entry 9 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,094 Underlying: Common Stock · 12,092 shares Expires 2033-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The Stock option was granted on March 5, 2023 and vests 1/48th of the shares monthly from the vesting commencement date of March 5, 2023 over a four year period thereafter, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:17 UTC |
Nouri AlalehEVP, CLO, CORP. SEC.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,162 | $0.00 Strike: $34.99 | $0.00 |
DisclosureSEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · derivative · entry 8 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,728 Underlying: Common Stock · 4,162 shares Expires 2032-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The Stock option was granted on March 31, 2022 and vested 1/48th on the anniversary of the vesting commencement date of March 15, 2022, and vesting monthly over a four year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:17 UTC |
Nouri AlalehEVP, CLO, CORP. SEC.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 11,838 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · derivative · entry 7 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,056 Underlying: Common Stock · 11,838 shares Expires 2031-06-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The Stock option was granted on June 22, 2021 and vested over a four year period. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:17 UTC |
Nouri AlalehEVP, CLO, CORP. SEC.
|
SaleCommon Stock | 8,118 | $97.90 | $794,752.20 |
DisclosureSEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · nonDerivative · entry 6 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,472 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 3, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.58 to $98.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:17 UTC |
Nouri AlalehEVP, CLO, CORP. SEC.
|
SaleCommon Stock | 16,187 | $96.98 | $1,569,815.26 |
DisclosureSEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · nonDerivative · entry 5 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,590 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 3, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.56 to $97.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:17 UTC |
Nouri AlalehEVP, CLO, CORP. SEC.
|
SaleCommon Stock | 3,787 | $96.12 | $364,006.44 |
DisclosureSEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · nonDerivative · entry 4 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 3, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.55 to $96.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:17 UTC |
Nouri AlalehEVP, CLO, CORP. SEC.
|
Exercise / conversionCommon Stock | 12,092 | $37.02 | $447,645.84 |
DisclosureSEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · nonDerivative · entry 3 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:17 UTC |
Nouri AlalehEVP, CLO, CORP. SEC.
|
Exercise / conversionCommon Stock | 4,162 | $34.99 | $145,628.38 |
DisclosureSEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · nonDerivative · entry 2 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,472 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:17 UTC |
Nouri AlalehEVP, CLO, CORP. SEC.
|
Exercise / conversionCommon Stock | 11,838 | $7.27 | $86,062.26 |
DisclosureSEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:12 UTC |
Zadno RezaDirector · President, CEO
|
SaleCommon Stock | 1,403 | $99.96 | $140,244.02 |
DisclosureSEC source: 0001628280-24-049561 · wk-form4_1733173968.xml · nonDerivative · entry 4 Zadno Reza · CIK 0001632326 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 179,185 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.77 to $100.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:12 UTC |
Zadno RezaDirector · President, CEO
|
SaleCommon Stock | 5,189 | $99.24 | $514,941.31 |
DisclosureSEC source: 0001628280-24-049561 · wk-form4_1733173968.xml · nonDerivative · entry 3 Zadno Reza · CIK 0001632326 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 180,588 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.75 to $99.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:12 UTC |
Zadno RezaDirector · President, CEO
|
SaleCommon Stock | 1,684 | $98.00 | $165,033.85 |
DisclosureSEC source: 0001628280-24-049561 · wk-form4_1733173968.xml · nonDerivative · entry 2 Zadno Reza · CIK 0001632326 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 185,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.74 to $98.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:12 UTC |
Zadno RezaDirector · President, CEO
|
SaleCommon Stock | 18,144 | $97.25 | $1,764,418.72 |
DisclosureSEC source: 0001628280-24-049561 · wk-form4_1733173968.xml · nonDerivative · entry 1 Zadno Reza · CIK 0001632326 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 187,461 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.74 to $97.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 21:07 UTC |
Zadno RezaDirector · President, CEO
|
SaleCommon Stock | 500 | $93.88 | $46,942.00 |
DisclosureSEC source: 0001628280-24-048972 · wk-form4_1732309658.xml · nonDerivative · entry 3 Zadno Reza · CIK 0001632326 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 205,605 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.62 to $94.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 21:07 UTC |
Zadno RezaDirector · President, CEO
|
SaleCommon Stock | 15,809 | $92.82 | $1,467,350.28 |
DisclosureSEC source: 0001628280-24-048972 · wk-form4_1732309658.xml · nonDerivative · entry 2 Zadno Reza · CIK 0001632326 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 206,105 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.51 to $93.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 21:07 UTC |
Zadno RezaDirector · President, CEO
|
SaleCommon Stock | 10,111 | $92.12 | $931,431.39 |
DisclosureSEC source: 0001628280-24-048972 · wk-form4_1732309658.xml · nonDerivative · entry 1 Zadno Reza · CIK 0001632326 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 221,914 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.51 to $92.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 21:28 UTC |
Zadno RezaDirector · President, CEO
|
SaleCommon Stock | 4,510 | $95.58 | $431,074.37 |
DisclosureSEC source: 0001628280-24-048105 · wk-form4_1731706118.xml · nonDerivative · entry 4 Zadno Reza · CIK 0001632326 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 232,025 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.31 to $96.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.